Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Asthma Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Asthma therapeutics. Synopsis In 2022, there will be more than 260.6 million diagnosed prevalent cases of A ... Read More
-
Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update Summary GlobalData's Medical Devices sector report, “Drugs of Abuse Pipeline Report including Stages of Development, Segments, Region and Countries, Regulato ... Read More
-
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape
Autoimmune Hepatitis Marketed and Pipeline Drugs Assessment, Clinical Trials, and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Autoimmune Hepatitis therapeutics. Synopsis In 2022, there will be more than 36.000 diagnose ... Read More
-
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Tr ... Read More
-
Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031
Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031 Summary ASD is one of the most common developmental disorders worldwide. The condition affects 4% of children worldwide, making the disease exceedingly prevalent. ASD is diagnosed when individuals have difficulty communicating wi ... Read More
-
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Hypertriglyceridemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, ... Read More
-
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031
Osteoarthritis Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021 - 2031 Summary Osteoarthritis (OA) is the most common joint disease and a major cause of disability and pain among the elderly in ... Read More
-
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update
Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update Summary GlobalData's clinical trial report, “Leishmaniasis (Kala-Azar) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, En ... Read More
-
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Schizophrenia Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The diso ... Read More
-
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
HER2- Breast Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in HER2- Breast Cancer therapeutics. Synopsis In 2022, there will be more than one million incide ... Read More
-
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Hospital Acquired Pneumonia Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Hospital Acquired Pneumonia therapeutics. Synopsis In 2022, there will be more than 30 ... Read More
-
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Urticaria Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Urticaria therapeutics. Synopsis In 2022, there will be more than 80 million diagnosed prevalent cases o ... Read More
-
Methicillin-Resistant Staphylococcus Aureus (MRSA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Methicillin-Resistant Staphylococcus Aureus (MRSA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in MRSA therapeutics. Synopsis In 2022, there will be more than 85 ... Read More
-
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Fungal Infections Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Fungal Infections therapeutics. Synopsis In 2022, there will be more than three million incident ... Read More
-
Age-Related Macular Degeneration Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Age-Related Macular Degeneration Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Macular degeneration is the breakdown of the macula, a small, oval-shaped area of the retina that ... Read More
-
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research
Pharmaceutical Drug Development Sector Scorecard, Q2 2022 Update - Thematic Research Summary The Genomics Landscape Continues to Be Dynamic in Q2 2022 With Less Activity Seen in Immuno-oncology. The genomics landscape was active in Q2 2022, with scores increased for several companies. This includes ... Read More
-
Artificial Intelligence (AI) in Drug Discovery - Thematic Research
Artificial Intelligence (AI) in Drug Discovery - Thematic Research Summary In recent years, driven by the COVID-19 pandemic, the pharma industry has undergone increased levels of digital transformation. The availability of ultra-large datasets and technological advances has led to more interest in t ... Read More
-
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Interstitial Cystitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Interstitial Cystitis therapeutics. Key Highlights In 2022, there will be more than one mill ... Read More
-
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Polymyositis and Dermatomyositis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Polymyositis and Dermatomyositis therapeutics. In 2022, there will be more than 3 ... Read More
-
Focal Segmental Glomerulosclerosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Focal Segmental Glomerulosclerosis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Focal Segmental Glomerulosclerosis therapeutics. Key Highlights In 2022, there ... Read More
-
Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
Nontuberculous Mycobacteria (NTM) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary Diagnosed prevalent cases of Nontuberculous Mycobacteria (NTM) infections are expected to increas ... Read More
-
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Major Depressive Disorder Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Major Depressive Disorder therapeutics. Synopsis In 2022, there will be more than 18 mil ... Read More
-
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Rosacea therapeutics. Synopsis In 2022, there will be more than 47 million diagnosed prevalent cases of ro ... Read More
-
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Aicardi-Goutieres Syndrome Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Aicardi-Goutieres Syndrome therapeutics. Synopsis There will be more than 4,000 prevale ... Read More
Research Assistance
